Global Coronary Stents Market Poised to Reach USD 57.9 Billion by 2035, Driven by Advanced Stent Technologies and Increasing Cardiovascular Disease Prevalence | FMI

The global coronary stents market is expected to experience robust growth over the next decade, surging from an estimated USD 35.5 billion in 2025 to a projected USD 57.9 billion by 2035. This represents a compound annual growth rate (CAGR) of 5.6%, driven by a growing demand for advanced stent technologies, rising incidence of coronary artery disease (CAD), and a globally aging population.

Coronary stents—small, mesh-like tubes inserted into narrowed or blocked arteries—are essential in restoring blood flow following angioplasty and are a key treatment for CAD. Among these, drug-eluting stents (DES) have emerged as the gold standard, offering superior outcomes by releasing medication that prevents arterial re-narrowing (restenosis).

Stay Updated with Market Movements: Get Your Sample Report! https://www.futuremarketinsights.com/report-sample#5245502d47422d31393933

Key Market Insights and Trends

1. Surge in Demand for Drug-Eluting Stents (DES)

By 2025, DES are projected to account for a commanding 33.2% of the total coronary stents market, making them the leading product segment. These stents have proven particularly effective in complex cardiovascular procedures due to their ability to mitigate restenosis through localized drug delivery.

The heightened demand for DES is largely attributed to the rising prevalence of coronary artery disease and the increasing number of high-risk cardiovascular patients globally. These stents are particularly beneficial in patients with comorbidities or those undergoing repeat procedures.

1. Hospitals Continue to Lead as Primary End Users

Hospitals are expected to represent 27.1% of the market share in 2025, remaining the primary healthcare setting for coronary stent procedures. The availability of advanced interventional cardiology units, expert medical professionals, and comprehensive post-operative care—including medication management and follow-up angiograms—positions hospitals as the preferred setting for complex interventions.

Further, advancements in hospital-based infrastructure, especially in developing regions, are playing a significant role in improving access to quality cardiac care.

1. Technological Advancements Powering Market Growth

One of the most significant contributors to the market’s growth is continuous innovation in stent technology. The development of biodegradable stents, bioabsorbable materials, and next-generation drug-eluting coatings is reshaping patient outcomes. Manufacturers are increasingly focused on creating stents that reduce post-surgical complications and improve long-term cardiovascular health.

Additionally, newer production methodologies are emphasizing sustainable manufacturing, which reduces environmental impact, waste, and energy usage—further enhancing market appeal.

Expanding Market Need: Access Our Full Report for In-Depth Analysis and Trends! https://www.futuremarketinsights.com/reports/coronary-stents-market

Key Takeaways

• By Product:
  • Drug-Eluting Stents (DES) are expected to lead the coronary stent market with a market share of 33.2% in 2025. DES help prevent restenosis by releasing drugs that inhibit scar tissue formation, a key benefit in treating coronary artery disease, which has been rising globally. DES is particularly beneficial in challenging surgical cases, driving their demand in the market.
• By End User:
  • Hospitals are projected to hold 27.1% of the coronary stents market share in 2025. This is due to the advanced clinical facilities, specialized cardiology departments, and modern equipment available in larger medical centers, making them ideal settings for complex heart procedures. Hospitals also play a critical role in post-procedure care, including dosage control, angiogram follow-ups, and lifestyle advice, all contributing to patient recovery and stent longevity.
• Country-wise Analysis:
  • The USA is expected to grow at a CAGR of 1.5%.
  • Canada is forecasted to experience a higher growth rate of 2.7%.
  • Germany will see a CAGR of 1.6%, while France is projected to grow at 2.4%.
  • Italy leads with a CAGR of 2.9%, and the UK is expected to grow at a CAGR of 1.9% in the coronary stents market through 2025.

Competitive Landscape and Innovation

The coronary stents market has seen remarkable progress in product development and regulatory approvals over the past few years. Major players are focusing on expanding their product portfolios, enhancing product safety and effectiveness, and responding to the evolving needs of cardiologists and patients alike.

Notable Product Approvals and Launches:

• Elunir-Perl Drug-Eluting Stent by Medinol

Approved by the U.S. FDA in October 2023, the Elunir-Perl stent provides an effective and safe treatment option for patients with coronary artery disease, highlighting the trend of innovation focused on patient outcomes.

• Xience Sierra by Abbott Laboratories

Approved in 2018, Xience Sierra is a low-profile, highly flexible DES tailored for complex percutaneous coronary interventions (PCI). Available in smaller diameters and longer lengths, it has become a trusted option for intricate cardiac procedures.

• Resolute Onyx 2.0mm by Medtronic

Also approved in 2018, this drug-eluting stent is uniquely designed for patients with small coronary arteries, expanding the therapeutic possibilities for individuals with challenging anatomical features.

Leading Market Players

Several global medical device giants and innovators are playing a pivotal role in shaping the future of coronary stents:

• TERUMO CORPORATION
• Boston Scientific Corporation
• Medtronic
• Vascular Concepts
• B. Braun Melsungen AG
• BIOTRONIK SE & Co. KG
• Abbott Laboratories
• Biosensors International Group, Ltd.
• HEXACATH
• STENTYS SA

These companies are consistently investing in R&D, engaging in strategic collaborations, and expanding their global footprint to remain competitive in a rapidly evolving market.

Advantage Healthcare Insights to Outpace Competitors! https://www.futuremarketinsights.com/industry-analysis/therapeutic-device

Market Segmentation Overview

By Product:

• Drug Eluting Stents (DES)
• Bare Metal Stents (BMS)
• Bioabsorbable Stents
• Self-expanding Stents
• Balloon-expandable Stents

By End User:

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Other Healthcare Settings

By Raw Material:

• Cobalt-Chromium
• Stainless Steel
• Platinum-Chromium
• Nickel-Titanium
• Polymer

By Region:

• North America
• Latin America
• Western Europe
• South Asia & Pacific
• East Asia
• Middle East & Africa

Conclusion

As cardiovascular diseases continue to be the leading cause of death globally, the coronary stents market is uniquely positioned for substantial growth in the coming decade. Key trends such as the rise of DES, the growing role of hospitals, and the integration of cutting-edge materials and sustainable manufacturing practices are likely to define the next wave of progress in this space.

With a strong pipeline of innovative products, increasing healthcare investments in emerging economies, and a patient population that is both expanding and aging, the future of the coronary stents market looks promising—and lifesaving.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube